VC-backed Imara appoints new CEO
Cambridge, Massachusetts-based Imara Inc, a clinical-stage biopharmaceutical company, has named Dr. Rahul D. Ballal as CEO. Previously, Ballal was at Northern Biologics and Versant Ventures where he was chief business officer and an entrepreneur-in-residence, respectively. Imara is backed by New Enterprise Associates, Pfizer Venture Investments, Lundbeckfond Ventures, Bay City Capital and Alexandria Venture Investments.
13 June 2018•4 mins read
